Home > Research > Publications & Outputs > Reconsidering the reasons for heightened inflam...

Electronic data

  • Palmos_et_al._2020_JoAD_Accepted

    Rights statement: This is the author’s version of a work that was accepted for publication in journal of Affective Disorders. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Journal of Affective Disorders, 282, 2021 DOI: 10.1016/j.jad.2020.12.109

    Accepted author manuscript, 616 KB, PDF document

    Available under license: CC BY-NC-ND: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

Links

Text available via DOI:

View graph of relations

Reconsidering the reasons for heightened inflammation in major depressive disorder

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Reconsidering the reasons for heightened inflammation in major depressive disorder. / Palmos, AB; Chung, R; Frissa, S et al.
In: Journal of Affective Disorders, Vol. 282, 01.03.2021, p. 434-441.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Palmos, AB, Chung, R, Frissa, S, Goodwin, L, Hotopf, M, Hatch, SL, Breen, G & Powell, TR 2021, 'Reconsidering the reasons for heightened inflammation in major depressive disorder', Journal of Affective Disorders, vol. 282, pp. 434-441. https://doi.org/10.1016/j.jad.2020.12.109

APA

Palmos, AB., Chung, R., Frissa, S., Goodwin, L., Hotopf, M., Hatch, SL., Breen, G., & Powell, TR. (2021). Reconsidering the reasons for heightened inflammation in major depressive disorder. Journal of Affective Disorders, 282, 434-441. https://doi.org/10.1016/j.jad.2020.12.109

Vancouver

Palmos AB, Chung R, Frissa S, Goodwin L, Hotopf M, Hatch SL et al. Reconsidering the reasons for heightened inflammation in major depressive disorder. Journal of Affective Disorders. 2021 Mar 1;282:434-441. Epub 2021 Jan 7. doi: 10.1016/j.jad.2020.12.109

Author

Palmos, AB ; Chung, R ; Frissa, S et al. / Reconsidering the reasons for heightened inflammation in major depressive disorder. In: Journal of Affective Disorders. 2021 ; Vol. 282. pp. 434-441.

Bibtex

@article{f45b923e7a7c4b9f94f978d624831525,
title = "Reconsidering the reasons for heightened inflammation in major depressive disorder",
abstract = "BackgroundIncreased circulating pro-inflammatory markers have repeatedly been associated with major depressive disorder (MDD). However, it remains unclear whether inflammation represents a causal mechanism for MDD, or whether the association is influenced by confounding factors such as body mass index (BMI).MethodsTo better understand this complex relationship, we generated polygenic risk scores (PRS) for MDD and BMI in a population cohort and attempted to isolate the impact these potential risk factors have on adulthood inflammation. Peripheral blood samples were collected as part of the South East London Community Health study, where we generated individualized PRS for MDD and BMI and quantified inflammatory markers using multiplex ELISA-based technology. We performed linear regressions to investigate the effects of PRS for MDD and BMI on inflammatory marker levels.ResultsOut of 35 inflammatory markers, we found a nominal effect of PRS for MDD on interleukin-10. We also found a significant positive effect of BMI on nine inflammatory markers, of which the two most strongly affected markers, interleukin-6 (IL-6) and C-reactive protein (CRP), were also nominally predicted by BMI PRS.LimitationsThe study utilized a cross-sectional design with a moderately sized sample.ConclusionsOur findings suggest there may not be a shared genetic mechanism contributing to MDD and higher inflammatory marker levels. However, there may be shared genetic etiology between BMI and adulthood levels of CRP and IL-6. Therefore, polygenic risk scores for BMI may represent a useful indicator for heightened levels of inflammation in adulthood.",
author = "AB Palmos and R Chung and S Frissa and L Goodwin and M Hotopf and SL Hatch and G Breen and TR Powell",
note = "This is the author{\textquoteright}s version of a work that was accepted for publication in journal of Affective Disorders. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Journal of Affective Disorders, 282, 2021 DOI: 10.1016/j.jad.2020.12.109",
year = "2021",
month = mar,
day = "1",
doi = "10.1016/j.jad.2020.12.109",
language = "English",
volume = "282",
pages = "434--441",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Reconsidering the reasons for heightened inflammation in major depressive disorder

AU - Palmos, AB

AU - Chung, R

AU - Frissa, S

AU - Goodwin, L

AU - Hotopf, M

AU - Hatch, SL

AU - Breen, G

AU - Powell, TR

N1 - This is the author’s version of a work that was accepted for publication in journal of Affective Disorders. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Journal of Affective Disorders, 282, 2021 DOI: 10.1016/j.jad.2020.12.109

PY - 2021/3/1

Y1 - 2021/3/1

N2 - BackgroundIncreased circulating pro-inflammatory markers have repeatedly been associated with major depressive disorder (MDD). However, it remains unclear whether inflammation represents a causal mechanism for MDD, or whether the association is influenced by confounding factors such as body mass index (BMI).MethodsTo better understand this complex relationship, we generated polygenic risk scores (PRS) for MDD and BMI in a population cohort and attempted to isolate the impact these potential risk factors have on adulthood inflammation. Peripheral blood samples were collected as part of the South East London Community Health study, where we generated individualized PRS for MDD and BMI and quantified inflammatory markers using multiplex ELISA-based technology. We performed linear regressions to investigate the effects of PRS for MDD and BMI on inflammatory marker levels.ResultsOut of 35 inflammatory markers, we found a nominal effect of PRS for MDD on interleukin-10. We also found a significant positive effect of BMI on nine inflammatory markers, of which the two most strongly affected markers, interleukin-6 (IL-6) and C-reactive protein (CRP), were also nominally predicted by BMI PRS.LimitationsThe study utilized a cross-sectional design with a moderately sized sample.ConclusionsOur findings suggest there may not be a shared genetic mechanism contributing to MDD and higher inflammatory marker levels. However, there may be shared genetic etiology between BMI and adulthood levels of CRP and IL-6. Therefore, polygenic risk scores for BMI may represent a useful indicator for heightened levels of inflammation in adulthood.

AB - BackgroundIncreased circulating pro-inflammatory markers have repeatedly been associated with major depressive disorder (MDD). However, it remains unclear whether inflammation represents a causal mechanism for MDD, or whether the association is influenced by confounding factors such as body mass index (BMI).MethodsTo better understand this complex relationship, we generated polygenic risk scores (PRS) for MDD and BMI in a population cohort and attempted to isolate the impact these potential risk factors have on adulthood inflammation. Peripheral blood samples were collected as part of the South East London Community Health study, where we generated individualized PRS for MDD and BMI and quantified inflammatory markers using multiplex ELISA-based technology. We performed linear regressions to investigate the effects of PRS for MDD and BMI on inflammatory marker levels.ResultsOut of 35 inflammatory markers, we found a nominal effect of PRS for MDD on interleukin-10. We also found a significant positive effect of BMI on nine inflammatory markers, of which the two most strongly affected markers, interleukin-6 (IL-6) and C-reactive protein (CRP), were also nominally predicted by BMI PRS.LimitationsThe study utilized a cross-sectional design with a moderately sized sample.ConclusionsOur findings suggest there may not be a shared genetic mechanism contributing to MDD and higher inflammatory marker levels. However, there may be shared genetic etiology between BMI and adulthood levels of CRP and IL-6. Therefore, polygenic risk scores for BMI may represent a useful indicator for heightened levels of inflammation in adulthood.

U2 - 10.1016/j.jad.2020.12.109

DO - 10.1016/j.jad.2020.12.109

M3 - Journal article

C2 - 33422819

VL - 282

SP - 434

EP - 441

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -